ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$4.060
+$0.090 (+2.27%)
Day Range
$3.760 - $4.110
52 Week Range
$0.605 - $5.240
Volume
326.35K
Avg Volume (10D)
316.46K
Market Cap
$648.79M
Price Chart
Market Statistics
Open$3.970
Previous Close$3.970
Day High$4.110
Day Low$3.760
52 Week High$5.240
52 Week Low$0.605
Valuation
Market Cap648.79M
Shares Outstanding159.80M
Price to Book7.18
Trading Activity
Volume326.35K
Value Traded1.29M
Bid$3.950 × 1,426
Ask$4.120 × 150
Performance
1 Day2.27%
5 Day-0.25%
13 Week15.01%
52 Week505.97%
YTD-13.80%
Technical Indicators
RSI (14)55.62
50-Day SMA$3.464
200-Day SMA$3.048
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
